Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-877-5 | CAS number: 2923-16-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The in vitro mutagenicity studies used for potassium trifluoroacetate evaluation were performed with a reaction mass of potassium trifluoroacetate (TFAK) and potassium trifluoromethanesulphinate (TFSK). Since this reaction mass consists of 50% TFAK, the results are considered appropriate to evaluate the mutagenic effects of potassium trifluoroacetate. The reaction mass of potassium trifluoroacetate and potassium trifluoromethanesulphinate was tested in vitro for genetic mutations induction the bacterial reverse mutation assay and in mammalian cells and for clastogenic effects in a chromosomal aberration test. Based on the results it is concluded that the Reaction Mass of TFSK/TFAK does not exhibit any potential for mutagenicity.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The three genetic toxicity studies used for potassium trifluoroacetate evaluation were actually performed with a reaction mass of potassium trifluoroacetate (TFAK) and potassium trifluoromethanesulphinate (TFSK). Since this reaction mass consists of 50% TFAK, the results are considered appropriate to evaluate the mutagenic effects of potassium trifluoroacetate.
In vitro gene mutation study in bacteria
The Reaction mass of TFSK/TFAK was examined for mutagenic activity in the Ames test (OECD guideline 471 and GLP compliant) using Salmonella typhimurium strains TA1535, TA1537, TA98, TA100 and the tryptophan-requiring Escherichia coli strain WP2 uvrA, in the absence and presence of metabolic activation. All strains were treated with seven concentrations of the test substance, ranging from 5 to 5000 µg/plate. Negative controls and positive controls were run simultaneously with the test substance. The mean number of his+ and trp+ revertant colonies of the negative controls were within the acceptable range and the positive controls gave the expected increase in the mean number of revertant colonies. The test substance was not toxic to any strain, in both the absence and presence of S9-mix, as neither a decrease in the mean number of revertants nor a clearing of the background lawn of bacterial growth compared to the negative controls was observed. In both the absence and presence of S9-mix in all strains, Reaction mass of TFSK/TFAK did not induce a minimal 2-fold and/or dose related increase in the mean number of revertant colonies compared to the background spontaneous reversion rate observed with the negative control.
In vitro gene mutation study in mammalian cells
In a study according to OECD guideline 490 and in compliance with GLP, the Reaction mass of TFSK/TFAK was examined for its potential to induce gene mutations at the TK-locus of cultured mouse lymphoma L5178Y cells. No test-substance induced increase in the number of mutations was observed when tested up to limit concetntrations in the presence and absence of metabolic activation. The results of the frst experimen, 3-hour exposure, with and without metabolic activation was confirmed in a second experiment, 24-hour exposure without metabolic activation. Appropriate solvent and postive controls were induced and gave expected results. It is concluded that the test substance is negative for mutagenicity to mammalian cells under the conditions of the study.
In vitro cytogenicity / chromosome aberration study in mammalian cells
The Reaction mass of TFSK/TFAK was tested In a Chromosome Aberration Assay using Chinese hamster V79 lung cells performed according to OECD Guideline 473 and GLP. Two independent assays were conducted in the presence and absence of metabolic activation. The negative and positive controls gave valid results. No induction of chromosome aberrations in Chinese hamster V79 cells was observed following treatment with Reaction mass of TFSK/TFAK up to 5000 μg active ingredients/mL concentration; thus, there was no evidence of any genotoxic activity of the test item under the conditions of this study.
In vivo Micronucleus test
A GLP-compliant erythrocyte micronucleus test was performed according OECD guideline 474. Four groups of 5 to 15 male animals were dosed via oral gavage with vehicle or with the Reaction mass of TFSK/TFAK at doses of 500, 1000 and 2000 mg/kg bw. A positive control group (cyclophosphamide) was included. It was concluded that, under the conditions used in this study, no induction of micronuclei in bone marrow erythrocytes was observed following administration of Reaction mass of TFSK/TFAK to mice at up to and including 2000 mg active ingredients/kg bw/day; thus, there was no evidence of any genotoxic activity of the test item under the conditions of this study.
Regarding the overall negative results from the in vitro genotoxicity studies, potassium trifluoroacetate is considered to present no genotoxic activity potential.
Justification for classification or non-classification
Based on the available data, no classification for genotoxicity is proposed for potassium trifluoroacetate according to the CLP 1272/2008 Regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.